July 24, 2016 10:26 AM ET

Biotechnology

Company Overview of Oncimmune Holdings plc

Company Overview

Oncimmune Limited develops and commercializes products for the detection of cancerous. It develops autoantibody assay technologies that have the potential to early detection a range of solid cancer tumor types. It offers EarlyCDT-Lung, a blood test that is ordered by a doctor to aid in the risk assessment and early detection of lung cancer in high-risk patients and to stratify indeterminate pulmonary nodules for the risk of malignancy. The company is based in Nottingham, the United Kingdom.

Clinical Sciences Building

Nottingham City Hospital

Hucknall Road

Nottingham,  NG5 1PB

United Kingdom

19 Employees

Phone:

44 1158 231 869

Fax:

44 1158 231 958

Key Executives for Oncimmune Holdings plc

Oncimmune Holdings plc does not have any Key Executives recorded.

Oncimmune Holdings plc Key Developments

Oncimmune Holdings plc Appoints Julian Hirst as Non-Executive Director

Oncimmune Holdings plc announced the appointment of Julian Hirst to the company's Board as Non-Executive Director. Julian is currently Corporate Finance Director of Immunocore Limited and also runs a Single Family Office which represents a high profile hedge fund manager.

Oncimmune Holdings plc Announces Death of Robert Page, CFO and Director

Oncimmune Holdings plc announced the death of Robert (Bob) Page, the company's CFO and a director who died unexpectedly on 3 June 2016 from natural causes. The company has started the process to recruit a new CFO.

Oncimmune Holdings plc Signs Three US Distribution Agreements

Oncimmune Holdings plc announced it has entered into three further distribution agreements in the US for its EarlyCDT-Lung test. The three agreements have been signed with national and regional distributors and will increase the total salesforce to more than 140 across the US.

Similar Private Companies By Industry

Company Name Region
Abcodia Ltd. Europe
Abeterno Ltd. Europe
Abgentis Ltd. Europe
ADC Biotechnology Ltd Europe
Advanced Gel Technology Limited Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Oncimmune Holdings plc, please visit www.earlycdt-lung.co.uk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.